BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4398939)

  • 21. Pathological aspects on Parkinson's syndrome.
    Steg G
    Acta Neurol Scand Suppl; 1972; 51():139-50. PubMed ID: 4268105
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of catecholamines on the central nervous system. (1). Role of dopamine in the brain in animal behavioral changes].
    Kameyama T; Kisara K
    Nihon Yakurigaku Zasshi; 1966 Sep; 62(5):317-26. PubMed ID: 5298294
    [No Abstract]   [Full Text] [Related]  

  • 24. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
    Bartholini G; Tissot R
    Rev Med Liege; 1970 Sep; 25(18):591-607. PubMed ID: 5511964
    [No Abstract]   [Full Text] [Related]  

  • 26. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1971; 2(4):262-400. PubMed ID: 4340597
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of brain catecholamines in the regulation of ACTH secretion.
    Van Loon GR
    Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin.
    Ernst AM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):219-25. PubMed ID: 4262736
    [No Abstract]   [Full Text] [Related]  

  • 29. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine is an important neurotransmitter in the autonomic nervous system.
    Thorner MO
    Lancet; 1975 Mar; 1(7908):662-5. PubMed ID: 47084
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of central nervous system monoamines in regulation of anterior pituitary function].
    Scapagnini U; Annunziato L; Di Renzo GF; Lombardi G
    Probl Actuels Endocrinol Nutr; 1974; Serie 18():47-64. PubMed ID: 4157193
    [No Abstract]   [Full Text] [Related]  

  • 32. Striatal monoamines and reserpine and chlorpromazine rigidity.
    Jurna I
    Pharmacol Ther B; 1976; 2(1):113-28. PubMed ID: 178006
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuropharmacological review of hypothalamic releasing factors.
    Plotnikoff NP; Kastin AJ
    Adv Biochem Psychopharmacol; 1977; 17():81-107. PubMed ID: 411333
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine receptor in the reward system of the rat.
    Kadzielawa K
    Arch Int Pharmacodyn Ther; 1974 Jun; 209(2):214-26. PubMed ID: 4441165
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
    Poirier LJ; Langelier P; Bédard P; Boucher R; Larochelle L; Parent A; Roberge AG
    Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259
    [No Abstract]   [Full Text] [Related]  

  • 36. [Control of motor activity in relation to monoaminergic mechanisms].
    Poirier LJ; Larochelle L; Bédard P; Parent A
    Rev Can Biol; 1972; 31():Suppl:175-80. PubMed ID: 4403290
    [No Abstract]   [Full Text] [Related]  

  • 37. [Uptake and storage of catecholamines by adrenergic fibers of the central and peripheral nervous system. II. Preferential retention of noradrenaline].
    L'Hermite P
    Arch Anat Microsc Morphol Exp; 1969; 58(3):257-82. PubMed ID: 4316936
    [No Abstract]   [Full Text] [Related]  

  • 38. Antipsychotic drugs and catecholamine synapses. Summary of the session.
    Andén NE
    J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
    [No Abstract]   [Full Text] [Related]  

  • 39. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.